LD

LSP Dementia Fund

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

LSP Dementia Fund is a venture capital fund managed by Life Sciences Partners.

Investor Profile

LSP Dementia Fund has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Post Ipo Equity, Series B rounds (top funding stages).
  • Majority of deals are located in Belgium, The Netherlands, United States.
  • Strong thematic focus on Biotechnology, Artificial Intelligence (AI), Life Science.

Stage Focus

  • Series Unknown (33%)
  • Post Ipo Equity (33%)
  • Series B (33%)

Country Focus

  • Belgium (33%)
  • The Netherlands (33%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Life Science
  • Pharmaceutical
  • Genetics
  • Health Care
  • Precision Medicine
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LSP Dementia Fund frequently co-invest with?

BNP Paribas Fortis
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
MV
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Medicxi
Europe, England, United Kingdom, London
Co-Investments: 1
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
LH
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
GC
North America, Georgia, United States, Atlanta
Co-Investments: 1
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1

What are some of recent deals done by LSP Dementia Fund?

QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
New Amsterdam Pharma

Naarden, Noord-Holland, The Netherlands

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

BiotechnologyLife SciencePharmaceutical
Post Ipo EquityNov 23, 2022
Amount Raised: $235,000,000
Nobi

Antwerpen, Antwerpen, Belgium

Nobi is an AI-powered smart lamp.

Artificial Intelligence (AI)
Series UnknownJan 28, 2022
Amount Raised: $14,494,224